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Abstract: Considerable progress has been made in recent years toward elucidating the 
correlation among nanoscale topography, mechanical properties, and biological behavior 
of cardiac valve substitutes. Porcine TriCol scaffolds are promising valve tissue engineer-
ing matrices with demonstrated self-repopulation potentiality. In order to define an in vitro 
model for investigating the influence of extracellular matrix signaling on the growth pattern of 
colonizing blood-derived cells, we cultured circulating multipotent cells (CMC) on acellular 
aortic (AVL) and pulmonary (PVL) valve conduits prepared with TriCol method and under 
no-flow condition. Isolated by our group from Vietnamese pigs before heart valve prosthetic 
implantation, porcine CMC revealed high proliferative abilities, three-lineage differentiative 
potential, and distinct hematopoietic/endothelial and mesenchymal properties. Their interaction 
with valve extracellular matrix nanostructures boosted differential messenger RNA expression 
pattern and morphologic features on AVL compared to PVL, while promoting on both matrices 
the commitment to valvular and endothelial cell-like phenotypes. Based on their origin from 
peripheral blood, porcine CMC are hypothesized in vivo to exert a pivotal role to homeostati-
cally replenish valve cells and contribute to hetero- or allograft colonization. Furthermore, due 
to their high responsivity to extracellular matrix nanostructure signaling, porcine CMC could 
be useful for a preliminary evaluation of heart valve prosthetic functionality.
Keywords: blood-derived multipotent cells, self-repopulation potential, guided tissue 
engineering, TriCol decellularization procedure, ECM nanostructure signaling
Introduction
Scaffolds for valve tissue engineering1 are required to express structural properties 
enabling cell ingrowth upon implantation in vivo. In particular, the surface morphol-
ogy or nanotopography has been demonstrated to control cell behavior on biomaterials 
and thus tissue formation and function.2,3
Despite still showing clinical disadvantages,4–8 that is, calcification and structural 
degeneration,9,10 biological prostheses are commonly used for the replacement of 
diseased heart valves. In the last decade, several approaches based on decellularized 
xeno- or homografts have been developed to obtain optimal valve substitutes. In this 
scenario, tissue-engineered heart valve represents a promising therapeutic strategy to 
guarantee in vivo tissue remodeling and repair during lifetime.11,12
As demonstrated by several studies, the success of valve substitutes is strictly depen-
dent on the ability of scaffold to provide the correct biophysical cues for cell adhesion, 
migration, proliferation, and differentiation. The heart valves are characterized by a 
highly compartmentalized structure enforcing mechanical adaptation to environmental 
changes.13 The architectural pattern is complex and comprises 1) valvular endothelial 
cells (VECs) at the blood-contacting surfaces and valvular interstitial cells (VICs) in 
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the inner layers and 2) extracellular matrix (ECM), organized 
into a tri-layered structure ensuring high tensile strength and 
low flexural stiffness.13,14
The maintenance of structural and functional ECM 
integrity is highly relevant to preserve the mechanical 
behavior of decellularized valve matrices and avoid in vivo 
graft deterioration.6 Elastin defragmentation and extraction 
of glycosaminoglycans and water have been described fol-
lowing several decellularization procedure-based trypsin/
Triton X-100 treatment or sodium dodecyl sulfate.4,15 In 
contrast, sodium cholate- and deoxycholate-based methods 
are useful to achieve fully nude matrices, with high in vitro 
and/or in vivo repopulation potentialities.16–19
Recently, the development of decellularized xenografts 
or homografts with self-regeneration potential is considered 
as an attractive option to obtain novel viable replacements 
granting longer durability and avoiding the extensive in vitro 
cell conditioning. Various studies have already reported 
in situ recellularization of decellularized xenografts and 
homografts in animal models highlighting variable success 
rate in dependence on the adopted decellularization method 
or used graft typology (xenograft or homograft).20–23
Spina et al24 set up a technique for decellularization of 
heart valve leaflets minimally affecting collagenous elastic 
network. Combining Triton X-100 and cholate, the so-called 
TriCol procedure, has been reported to guarantee 1) the 
complete tissue decellularization, that is functional to control 
the development of calcification process;24 2) the removal of 
alpha-gal xenoantigens for avoiding the rejection of xeno-
genic grafts;25 3) the preservation of valve hemodynamic 
profile and performance; and 4) in vitro full biocompatibility 
with valve interstitial cells26 and bone marrow mesenchymal 
stem cells (BM-MSCs).16 Largely characterized by their 
composition of glycosaminoglycans, proteoglycans, ECM 
filaments,24,27 and nonpreconditioned TriCol heart valves 
showed a good hemodynamic profile and stable structural 
integrity in a long-term follow-up performed in allogeneic 
animal model.18
There is a general agreement that bone marrow stromal 
cells are recruited into circulation upon tissue damage or 
graft implantation and are involved in tissue repair and 
regeneration.28–30 Moreover, many authors suggest that 
stem cells could be mobilized by pharmacological treatment 
(ie, anesthesia) from their specific niche and circulate in 
the bloodstream, thereby participating in the regeneration 
processes of peripheral tissues.31 Recently, great interest 
has been focused on blood-derived stem cells in heart valve 
surgery as potential physiological and autologous mediators 
of the so-called guided valve tissue engineering.
To date, fibroblast-like multipotent cells with proliferative 
and multidifferentiative properties but distinct immunophe-
notypic features have already been identified in peripheral 
blood of different species of adult animals, such as guinea 
pig,32 rabbit,33 dog,34 mouse,35 rat,36 and humans.37,38
While processing the peripheral blood of Vietnamese 
pigs (VPs) sedated before heart valve surgery, we recently 
isolated a population of multipotent adherent cells that fulfill 
some MSC criteria, as defined by the International Society 
for Cellular Therapy.29 Due to similarities with human 
circulating cells previously described,38 we have named these 
cells “porcine circulating multipotent cells” (pCMC) and 
experimentally used to explore the repopulation potential 
of porcine heart valves decellularized with TriCol procedure 
(Figure 1). Under no-flow culture condition, pCMC have 
been showed to be differentially stimulated by AVL and 
PVL and expressed gene markers correlatable to VIC- and 
VEC-like phenotypes.
Materials and methods
scaffold preparation
Aortic valve (AV) and pulmonary valve (PV) were isolated 
from common breeding piglets (3 to 4 months old) and used 
for preparing acellular aortic valve leaflets (AVL) and acel-
lular pulmonary valve leaflets (PVL). Hearts were washed 
in sterile phosphate-buffered saline (PBS) supplemented 
with penicillin 100 U/mL, streptomycin 100 mg/mL, and 
amphotericin B 250 mg/mL (all from Sigma-Aldrich Co., 
St Louis, MO, USA). Decellularization was performed by 
TriCol treatment as previously described by Bertipaglia 
et al.26 Nucleic acids (DNA/RNA) were removed using two 
successive 24-hour periods at 37°C under constant stirring 
according to endonuclease Benzonase protocol (Merck 
Chemicals Ltd, Nottingham, UK).24 The effective DNA 
removal in TriCOL-treated valves was verified by 4,6-
diamidino-2-phenylindole (DAPI) staining of histological 
sections (5 µm thick) of AVL and PVL. Before cell seeding, 
AVL and PVL were preconditioned with bovine fibronectin 
(10 µg/cm2, 24 hours at 37°C; Calbiochem, Billerica, MA, 
USA) to enhance the adhesion of pCMC.
Blood cells
Samples (10 mL) were collected from 9 months to 12 months 
old healthy VPs that were sedated according to the procedure 
previously reported.19 VPs were provided by CISRA Institute 
(120TO025 – ASL 3 Collegno, Torino, Italy). All experiments 
were performed under authorization of the Italian Ministry 
of Health (project registration number 27/08 C16), accord-
ing to the principles given by ISO 10993-2 (ISO 10993-2 
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Biological Evaluation of Medical Devices part 2: Animal 
Welfare Requirements: EN ISO 10993, 2003).
Cell isolation was performed using density gradient sepa-
ration technique and Histopaque-1077 (Sigma-Aldrich Co.). 
Blood samples were diluted 1:1 with PBS and carefully layered 
on Histopaque-1077 solution. Following centrifugation at 
400× g, 4°C, mononuclear cells were collected, washed in 
PBS solution, and then seeded (1×106 cells/cm2) in polysty-
rene culture dishes (BD, Franklin Lakes, NJ, USA). Cultures 
were cultivated at 37°C, 95% humidity, and 5% CO
2
, in pro-
liferation culture medium prepared with alpha-modified eagle 
medium without nucleosides, 16.5% fetal bovine serum (FBS), 
1% antibiotic solution, and 1% glutamax (all from Thermo 
Fisher Scientific, Waltham, MA, USA). When fibroblast colo-
nies (fibroblast colony-forming units) were detected, culture 
medium was changed and cell expansion was performed. 
At 80% confluence, cells were detached using 0.02% ethylene-
diaminetetraacetic acid/0.25% trypsin solution (Sigma-Aldrich 
Co.), and subcultures were prepared with a seeding density of 
5×103 cells/cm2. All cultures were observed daily by optical 
microscope DM/IL (Leica Microsystems, Wetzlar, Germany), 
and pictures were taken with Nikon Digital Sight Ds-SMCc 
camera (Nikon Corporation, Tokyo, Japan).
scanning electron microscopy
The samples were fixed with 3% glutaraldehyde prepared 
in 0.1 M sodium cacodylate buffer (pH 7.4) (Sigma-Aldrich 
Co.), for 24 hours, at 4°C. After washing in sodium cacody-
late buffer, the dehydration of cells was carried out through a 
graded series of ethanol and submitted to critical point drying. 
Finally, the samples were coated with gold and observed by 
microscope JSM Jeol 6490 (JEOL, Tokyo, Japan).
Immunophenotyping
Short- (eighth generation) and long- (36th generation) term 
cultures were analyzed by flow cytometry for the expression 
of hematopoietic, endothelial, and MSC markers using 
anti-pig antibodies raised against target proteins reported 
in Table 1 and 2. The expression of alpha-smooth muscle 
????????????????????????
???? ???
??
???
?????????????
????????????????? ?????????????????????????????
??????????????? ?????????????
?????????
?????????????????????????
Figure 1 experimental design for in vitro study of pcMc-seeded matrices.
Abbreviations: pcMc, porcine circulating multipotent cells; DaPI, 4,6-diamidino-2-phenylindole; seM, scanning electron microscopy; Pcr, polymerase chain reaction; 
IF, immunofluorescence.
Table 1 Antibodies used for FCM and immunofluorescence 
analysis
Manufacturing company
Primary antibodies
Pe-cy7 mouse anti-pig cD34 BD Biosciences
Mouse anti-pig cD44 abD serotec
Pe mouse anti-pig cD45 santa cruz Biotecnology, Inc.
Pe mouse anti-pig cD90 santa cruz Biotecnology, Inc.
Pe mouse anti-pig cD105 santa cruz Biotecnology, Inc.
Mouse anti-pig cD106 abD serotec
Mouse anti-pig cD133 Miltenyi Biotec
Mouse anti-pig cXcr4 santa cruz Biotecnology, Inc.
Mouse anti-pig sla-Dr abD serotec
FITc rabbit anti-pig α-sMa abcam
rabbit anti-pig vWF abcam
secondary antibodies
Pe goat anti-mouse santa cruz Biotecnology, Inc.
FITc goat anti-mouse abD serotec
alexaFluor®488 goat anti-rabbit Thermo Fisher Scientific
Isotype controls
Pe isotype control santa cruz Biotecnology, Inc.
Pe-cy7 isotype control BD Biosciences
Abbreviations: FCM, flow cytometry; PE, phycoerythrin; PE-Cy7, phycoerythrin–
cyanine7; cXcr4, c-X-c chemokine receptor type 4; sla-Dr, swine leukocyte 
antigen DR; FITC, fluorescein isothiocyanate; α-sMa, alpha-smooth muscle actin; 
vWF, von Willebrand factor.
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actin (α-SMA) was evaluated by immunofluorescence (IF) 
using a fluorescein isothiocyanate-conjugated rabbit anti-pig 
α-SMA antibody (Abcam, Cambridge, UK). After mount-
ing with Fluoro-Gel II solution containing DAPI (Electron 
Microscopy Sciences, Hatfield, PA, USA), the samples were 
analyzed using a Leica TCS SP5 confocal microscope (Leica 
Microsystems). As negative controls, isotype or secondary 
antibodies-matched samples were used (Table 1). Flow 
cytometry analysis was performed using MOFLO High-
Speed Cell Sorter (DAKO-Beckman Coulter Inc, Brea, 
CA, USA) and Summit 4.3 software (DAKO-Beckman 
Coulter Inc.). Data were reported as mean percentage of 
positive cells ± SD of three independent experiments per-
formed in triplicate.
Proliferation capacity
The proliferation and senescence rate of pCMC was evalu-
ated culturing for 36 consecutive passages by seeding in 
triplicate each generation at a density of 5×103 cells/cm2. 
At an interval of 24 hours, the cells were detached using 
ethylenediaminetetraacetic acid/trypsin solution and counted. 
The average number of cells ± SD for each passage was used 
to calculate the doubling population time.
Differentiative plasticity
The cells were seeded at a density of 3×103 cells/cm2 and 
induced to differentiate under the conditions described later. 
In parallel, cells cultured in proliferation medium were 
used as control. After 7 days and 14 days, cytochemical, 
colorimetric, and IF analyses were performed to confirm the 
lineage-specific differentiation.
adipogenic induction
The samples were cultured in Dulbecco’s Modified Eagle’s 
Medium high-glucose medium (Sigma-Aldrich Co.) supple-
mented with 10% FBS (Thermo Fisher Scientific), 1% antibiotic 
solution (Sigma-Aldrich Co.), and adipogenic supplements 
(1 mM dexamethasone, 0.5 mM 3-isobutyl-1-methylxanthine, 
10 mg/mL insulin, 60 mM indomethacin) (all from Sigma-
Aldrich Co.). To detect intracellular lipid droplets, the cells 
were fixed with 10% formalin solution (Sigma-Aldrich Co.) 
and stained with Oil Red O solution (5 mg/mL in isopropanol) 
(Sigma-Aldrich Co.). Nuclei were counterstained with hema-
toxylin (Sigma-Aldrich Co.) according to standard procedure.
Osteogenic induction
For the analysis of osteogenic potentiality, we cultured pCMC 
using collagen I-coated plates (Sigma-Aldrich Co.) and 
alpha-modified eagle medium supplemented with 10% FBS, 
1% antibiotic solution, and osteogenic supplements (100 nM 
dexamethasone, 10 mM β-glycerophosphate, 0.05 mM ascorbic 
acid-2-phosphate) (all from Sigma-Aldrich Co.). To verify the 
formation of calcium deposits in stimulated cultures, an osteo-
genesis assay kit (EMD Millipore, Billerica, MA, USA) was 
used. After fixation with 10% formalin solution for 15 minutes, 
the samples were washed twice with distilled water and then 
incubated with Alizarin Red S according to manufacturer’s 
instructions. After the addition of ammonium hydroxide, the 
amount of the extracted Alizarin Red dye was measured at 
562 nm and quantified using an Alizarin Red S standard curve. 
Data were expressed as the mean concentration (µM) ± SD of 
three separate experiments performed in triplicate. Unstimu-
lated samples were used as control. Statistical significance was 
calculated using Student’s t-test comparing to controls.
cardiomyogenic induction
Cells were treated with Dulbecco’s Modified Eagle’s Medium 
low glucose (Thermo Fisher Scientific), 20% FBS (Sigma-
Aldrich Co.), 1% antibiotic solution (Sigma-Aldrich Co.), 1% 
glutamax (Thermo Fisher Scientific), and 6 mM 5-azacytidine 
(Sigma-Aldrich Co.). To assess the specific lineage induc-
tion, we performed an indirect IF assay using Vectastain 
ABC system (Vector Laboratories, Inc., Burlingame, CA, 
USA) and mouse anti-pig α-cardiac actin (actin alpha 
cardiac muscle 1), mouse anti-pig cardiac troponin T, and 
mouse anti-pig phospholamban primary antibodies (all from 
Acris, San Diego, CA, USA). The analysis of samples was 
executed with Leica TCS-SP5 confocal microscope and LAS 
AF software (Leica Microsystems).
cell seeding on acellular valve matrices
After several washings in PBS solution, the valve matrices 
were maintained in 50% FBS solution for 12 hours at 37°C 
before cell seeding. The cells were seeded in proliferation 
medium at a density of 6.5×105 cells on the ventricularis side 
of leaflets (0.5 cm2). Using no-flow condition, the samples 
were cultured in vitro up to 35 days performing the change 
of medium every 2 days. At different time points (7 days, 
14 days, 28 days, and 35 days), the constructs were fixed and 
analyzed by reverse transcription–polymerase chain reac-
tion (RT-PCR), scanning electron microscopy (SEM), and 
IF staining. Native AV and PV were used as reference.
One-step rT-Pcr
Total cellular RNA was extracted using TRIzol® (Thermo 
Fisher Scientific). After treatment with RNase-Free DNase 
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Set (Qiagen NV, Venlo, the Netherlands), the samples 
were quantified by measuring the absorbance at 260 nm. 
Fifty nanograms of RNA were reverse transcribed and 
amplified using One Step RT-PCR Kit (Qiagen) according 
to the manufacturer’s instructions. Transcripts encoding 
endothelial, VIC, VEC, and ECM proteins were investigated 
using oligonucleotides listed in Table 3. PCR products were 
electrophoresed on 2% agarose gel (Sigma-Aldrich Co.), 
prestained with GelRedTM and then visualized by UV 
transilluminator Gel Doc 2000 (Bio-Rad Laboratories Inc., 
Hercules, CA, USA). The quantification of amplicon density 
band was calculated for each target gene using ImageLab 
software (Bio-Rad Laboratories Inc.) considering three 
independent experiments performed in triplicate. Data were 
reported as ratio within target and housekeeping (glyceral-
dehyde 3-phosphate dehydrogenase) gene expression level. 
Statistical significance was calculated by the Wilcoxon test 
comparing the expression profile of 1) pCMC grown on 
polystyrene dishes and control native valves (AV and PV) or 
2) pCMC cultured on valve leaflets against samples cultured 
for 7 days (D7).
IF staining
To evaluate the growth of pCMC on AVL and PVL surface 
matrices, histological sections of constructs and native AV 
and PV were prepared, fixed in 10% formalin solution at 
different time points of culture (D7, D14, D28, and D35), 
and thus stained with Fluoro-Gel II solution containing 
DAPI. In parallel, the expression of CD44, CD106, and 
von Willebrand factor was evaluated by indirect IF and 
using the antibodies listed in Table 1. In parallel, secondary 
antibody-matched samples were used as negative controls. 
The acquisition of images was performed using a Leica TCS 
SP5 confocal microscope.
Results
cell isolation and morphological study
After 15–20 days from seeding, typical fibroblast colony-
forming units were detected with a frequency of 0.7±0.02/106 
nucleated cells. The cells gave rise in short-term cultures 
(from 0 to 10th passage) to heterogeneous populations with 
spindle-shaped morphology (Figure 2A) and pseudopodia-
like membrane projections (Figure 2B). After prolonged 
in vitro expansion (from 11th to 36th passages), the mor-
phological features were retained (Figure 2C).
growth kinetics
Our data evidenced a linear relationship between population 
doublings and generation number with a doubling time 
of ~16 hours (Figure 2D).
????????????????????????????
??????????????????????????????????????????
????????????????????????????????????????????????????
????????????????????????????
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Figure 2 Phenotypic characterization of pcMc cells.
Notes: analysis of morphological, proliferative, and immunophenotypic features of short-term (0–10th passages) (A, B, E, G) and long-term (11th–36th passages) (C, F, G) 
pcMc cultures. (A, C) Phase-contrast microscopy. (B) seM analysis. (D) growth kinetics and calculation of doubling population time over a total of 36 divisions. (E, F) 
Flow cytometric analysis. Data are reported as mean percentage of positive cells ± sD of three independent experiments performed in triplicate. (G) IF detection of α-sMa. 
Bar: 25 µm.
Abbreviations: pCMC, porcine circulating multipotent cells; IF, immunofluorescence; ND, not detected; CXCR4, C-X-C chemokine receptor type 4; SLA-DR, swine 
leukocyte antigen Dr; α-sMa, alpha-smooth muscle actin; DaPI, 4,6-diamidino-2-phenylindole.
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Immunophenotype
The immunophenotype of pCMC was determined by flow 
cytometry (Figure 2E and F) and IF (Figure 2G) using the anti-
bodies listed in Table 1. The short-term cultures were shown to 
express hematopoietic (CD34), endothelial (CD133), and typi-
cal MSC markers (CD44, CD106, CD90, α-SMA) (Figure 2E 
and G). CD45, a hematopoietic lineage-restricted antigen, 
CD105, a receptor for TGF-β1 and -β3, and C-X-C chemokine 
receptor type 4, a stromal-derived-factor-1 receptor, were not 
detected (Figure 2F and G). Swine leukocyte antigen DR was 
present on a small subpopulation and showed to be modulated 
during in vitro culture (Figure 2E and F). Upon long-term 
expansion, the expression level of CD44, CD106, CD133, and 
α-SMA unchanged, while a decreased positivity for CD34 and 
CD90 was observed (Figure 2F and G). As shown in Table 2, 
the comparison with other blood-derived stem cells confirmed 
for pCMC a distinctive immunophenotype.
Differentiative potential
After specific differentiation induction, the plasticity of 
pCMC toward adipogenic, osteogenic, and cardiomyogenic 
lineage was demonstrated evaluating the accumulation of 
lipid droplets (Figure 3A), the synthesis of mineralized ECM 
(Figure 3B), and the expression of specific cardiomyogenic 
markers such as phospholamban (Figure 3C), actin alpha car-
diac muscle 1 (Figure 3D), and cardiac troponin T (Figure 3E). 
Upon prolonged in vitro expansion, the differentiative 
response of pCMC unchanged.
cellular response to valve matrix 
signaling
gene expression study
Using the oligonucleotides listed in Table 3, the gene expres-
sion pattern of native heart valves was defined exploring 
clusters of messenger RNAs (mRNAs) relevant to VICs and 
VECs functionality or valve regeneration process (Figures 4 
and S1). Before seeding on valve matrices, pCMC showed 
an active gene transcription for ECM components (fibrillin 
[FBN1], emilin [EMILIN1], collagen I [COL1A1], collagen III 
[COL3A1], and tenascin C [TNC]), angiogenic/cytoskeleton 
reorganization markers (caldesmon 1 [CALD1]), and matrix 
degrading enzymes (metalloproteinase [MMP] 2). The growth 
on AVL and PVL affected the gene expression of pCMC 
reducing drastically mRNA synthesis at early and intermediate 
phases (from D7 to D28) while promoting a differential gene 
expression pattern at longer time point (D35) between engi-
neered aortic and pulmonary conduits. In particular, pCMC 
cultured on AVL showed a significant mRNA expression of 
MMP2, MMP13, COL3A1, COL4A1, TNC, and vascular 
endothelial growth factor A (VEGFA). In contrast, the cell 
interactions with PVL were effective to boost the transcrip-
tion of COL3A1, FBN1, EMILIN1, COL1A1, TNC, CALD1, 
and VEGFA. As shown by DAPI staining in Figures 5 and 6, 
pCMC colonized the surface of both ventricularis and fibrosa 
layers, thus suggesting that the cellular response evaluated by 
gene expression study could be mediated by the interactions 
of pCMC with both inflow and outflow layers.
Morphological analysis of pcMc-seeded matrices
Using AV (Figure 5A) and PV (Figure 6A) as control, the mor-
phological study of the inflow surface of acellular matrices was 
performed by SEM before (Figures 5A[a] and 6A[a]) and after 
(Figures 5C, E, G, and I and 6C, E, G, and I) the seeding of 
pCMC. In parallel, DAPI staining was used to investigate the 
TriCol efficacy of cellular removal and to track the growth and 
distribution of pCMC on acellular matrices during 35 days of 
in vitro culture. As shown in Figures 5 and 6, the ventricularis 
surface of TriCol-treated valves was demonstrated to be com-
pletely decellularized and formed of ECM fibrillary network 
(Figures 5A[a] and 6A[a]). The cells adhered to both valve 
conduits and spread, acquiring fibroblastic morphology from 
early-(D7) to intermediate-(D35) in vitro culture (Figures 5C–I 
and 6C–I). The adhesion to matrix was preserved for all the 
evaluation period of 35 days, and the growth was detected by 
DAPI staining at the ventricularis (early phase) and fibrosa 
layers (intermediate/late phase). As expected from engi-
neered constructs cultured in vitro under no-flow condition, 
Table 2 Immunophenotypic profile of different classes of 
circulating stem cells
Marker pCMC BM-MSC HSC EPC BD-MSC MOMCs
cD14 - - - - +
cD34 + - +/- + - +
cD44 + + +/- - + -
cD45 - - + - - +
cD90 + + + + + -
cD105 - + + + + +
cD106 + + + + + -
cD133 + - + + -
cXcr4 - + + + -
hla-Dr/sla-Dr + - - - +
collagen I + + - + +
α-sMa + + - - -
vWF - - - + -
Notes: +, expression; -, no expression. Data from studies.29,45–50
Abbreviations: pcMc, porcine circulating multipotent cells; BM-Msc, bone 
marrow mesenchymal stem cells; hsc, hematopoietic stem cells; ePc, endothelial 
progenitor cells; BD-Msc, blood-derived mesenchymal stem cells; MOMcs, 
monocyte-derived multipotential cells; cXcr4, c-X-c chemokine receptor type 4; 
hla-Dr, human leukocyte antigen; sla-Dr, swine leukocyte antigen Dr; α-sMa, 
alpha-smooth muscle actin; vWF, von Willebrand factor.
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no DAPI-stained cells were detectable in the inner parts of 
matrices (Figures 5B[b] and 6B[b]) compared to native tissues 
(Figures 5A and B and 6A and B).
Interestingly, SEM analysis provided insights into the 
effects of ECM nanostructures and physical forces on cell 
changes in cytoskeletal actin filaments and spatial orientation. 
It is known that the ventricularis contains multidirectionally 
oriented collagen fibers and an extensive network of elastic 
fibers mostly oriented perpendicular to the free edge of the 
cusp. As predictable, a more tight distribution pattern of 
collagen and elastic fibers was observed in AVL ventricu-
laris compared to PVL inflow layer (Figures 5 and 6). The 
SEM of engineered conduits showed that pCMC retained 
elongated morphology during in vitro culture on AVL matrix 
and aligned parallel to the long axis. Conversely, the cells 
grown on PVL matrices switched from typical fibroblastic-
like morphology to polygonal shape at D28, coinciding with 
the increased mRNA synthesis of ECM components. In both 
AVL and PVL, pCMC resembled morphologically the mature 
endothelial cells of the corresponding native valves.
Immunofluorescence
We demonstrated that TriCol matrices preserve long-term 
survival of pCMC by investigating the protein expression of 
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Figure 3 study of differentiative potentialities of pcMc versus adipogenic (A), osteogenic (B), and cardiomyogenic (C–E) lineages. 
Notes: (A) Detection of cytoplasmic lipid droplets by Oil red O staining after adipogenic stimulation for 14 days. Nuclei were counterstained with hematoxylin. Data from 
unstimulated samples were reported in the right down corner. Bar: 25 µm. (B) alizarin red staining to evaluate calcium deposits in cultures grown in osteogenic (treated) and 
proliferative (untreated) medium for 7 days (D7) and 14 days (D14). The amount of extracted Alizarin red dye was measured at 562 nm and quantified using an Alizarin red 
s standard curve. Data were expressed as the mean concentration (µM) ± SD from three separate experiments performed in triplicate. Statistical significance was calculated 
using student’s t-test comparing to untreated samples (*P#0.05). IF analysis of (C) PlN, (D) acTc1, and (E) TNNI3 in cells stimulated for 14 days with cardiomyogenic 
medium. Unstimulated cells (right down corner) were used as control. Nuclei were counterstained with DaPI. scale bar: 10 µm.
Abbreviations: pCMC, porcine circulating multipotent cells; IF, immunofluorescence; PLN, phospholamban; ACTC1, cardiac muscle alpha actin; TNNI3, cardiac troponin I 
type 3; DaPI, 4,6-diamidino-2-phenylindole.
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CD44 and CD106 in engineered AVL and PVL (Figure 7A–L). 
Both surface markers are useful indicators of cellular in vitro 
senescence occurring in MSCs. As it is reported that the 
decreased expression of these antigens correlates with a 
reduced viability of their corresponding ligands (hyaluronan 
and TGF-β, respectively), the investigation of CD44 and 
CD106 could provide insights into ECM remodeling by 
newly synthetized proteins. As shown in Figure 7, pCMC 
were organized into multilayered structure, much thicker in 
PVL than in AVL. A comparable expression of both markers 
was demonstrated in constructs cultured for 7 days (D7) and 
35 days (D35), indirectly suggesting the active synthesis by 
pCMC of structural and signaling molecules related to ECM 
development and turnover. In parallel, we detected also the 
expression of von Willebrand factor, an endothelial marker 
commonly correlated with in vitro re-endothelialization of 
decellularized heart valves (Figure 7M–R).
Discussion
Obtaining heart valve substitutes (HVs) with longer dura-
bility and functionality is still an elusive goal in clinics. 
Valve acellular matrices consist of nanostructured grooves, 
ridges, pits, pores, and fibrillary networks composed mostly 
of collagen and elastin fibers with diameters ranging from 
100 nm to 300 nm suggesting to exert a regulatory role during 
tissue regeneration. Recently, new methodologies of decel-
lularization have been experimented in tissue engineering for 
improving the in vivo performance of HVs.39 Mimicking the 
three-dimensional structure and nanotopography of native 
tissues, the porcine valve conduits prepared accordingly to 
the TriCol protocol16,25,26 demonstrated in preclinical models 
a great chance of success in 1) promoting a spontaneous 
guided tissue regeneration39 and 2) overcoming the typical 
drawbacks of valve graft transplantation, that is, high risk 
of calcification, fibrosis, and immunological reaction.19 The 
successful cell integration and differentiation into tissue-
specific phenotypes are demonstrated to be driven by the 
optimized hemodynamic profile, mechanical stress, and 
matrikine signaling of HVs. Moreover, based on the immu-
nophenotypic characterization of cells isolated from the 
explanted heart valve conduits, the complex phenomenon of 
valve repopulation is reported to be boosted in early phase 
by BM-MSCs mobilized into circulation upon surgical 
intervention. Our present data demonstrate that multipotent 
cells circulating in the peripheral blood before the implanta-
tion of TriCol valve matrices show in vitro specific responsiv-
ity to valvular structural and mechanical stimuli suggesting 
their potential in vivo contribution to the development of 
both endothelial and mesenchymal/interstitial phenotypes 
within valve implants.
During valve development, embryonic progenitor 
endothelial cells overlying the endocardial cushion undergo 
endothelial mesenchymal transition, giving rise to the so-
called VICs, the most prevalent valve cellular phenotype 
of mature valves.40,41 In adult life, VICs are physiologically 
controlled by environmental factors, exhibit distinct cellular 
Table 3 Oligonucleotides used for the qPcr analysis
Gene Abbreviation Primer sequences Accession Amplicon length
Matrix metalloproteinase-2 MMP2 F: cggacaagagTTggcTgTgcaaT
r: agcTgggTggaagagaacacagTT
NM_214192.1 506 bp
Matrix metalloproteinase-13 MMP13 F: TcTTcTTgagcTggacccacTgTT
r: accTcTaagccgaagaaagacTgc
FJ263939.1 288 bp
Fibrilin FBN1 F: TgggaTTTaccgTgcTTTagcgT
r: cTcTggcacagacagTggTcaTca
NM_001001771.1 381 bp
Emilin eMIlIN1 F: acaagacagTgacggagaTggagT
r: TgcTgcTgcaTcTcaTTgagggTT
XM_003125303.1 399 bp
Alpha-1 type I collagen cOl1a1 F: gaaccaaagggcccaaaggTgaaa
r: agagggaccTTTcTcaccagcaaa
NM_001243655.1 301 bp
Alpha-1 type III collagen cOl3a1 F: agccagaacgaTgccaaaTaTgcg
r: TgcccTTTcaTaccagggaaTcca
XM_003133535.1 654 bp
Alpha-1 type IV collagen cOl4a1 F: acagTgccacTcTaTagcgggTTT
r: gTTTggcTgTgaaTggcTaTggca
XM_003131091.4 301 bp
Tenascin TNc F: TTcagTcggaaacagcccTTcTca
r: agaagacTTccagcTTcTgggcTT
NM_214230.1 347 bp
Caldesmon 1 calD1 F: agcTTcTTcggTggaaagaggga
r: aTcagaaggTTXgggagcaggTga
XM_003134653.1 854 bp
Vascular endothelial growth factor A VegFa F: TTcTgcTcTcTTgggTgcaTTgga
r: TgaTgTTgaacTccTcagTgggca
NM_214084.1 296 bp
Glyceraldehyde 3-phosphate 
dehydrogenase
gaPDh F: aaggTcggaagTcaacggaTTTggT
r: acaaagTggTgcTTgagggcaaTg
NM_001206359.1 450 bp
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Figure 4 gene expression study by one-step rT-Pcr on rNa extracted from native heart valves (aV: aortic; PV: pulmonary), pcMc cultured on polystyrene (pcMc) or 
seeded on acellular aortic (aVl) and pulmonary (PVl) valve matrices (pcMc/aVl, pcMc/PVl).
Notes: Data are representative of three independent experiments performed in triplicate. The gene expression level of gaPDh housekeeping was used as reference. Pcr 
products were electrophoresed on 2% agarose gel prestained with gelred™ and then visualized by UV transilluminator gel Doc 2000. Base pair: bp.
Abbreviations: rT-Pcr, reverse transcription–polymerase chain reaction; pcMc, porcine circulating multipotent cells; gaPDh, glyceraldehyde 3-phosphate dehydrogenase; 
MMP, matrix metalloproteinase; FBN1, fibrillin; EMILIN1, emilin 1; COL1A1, alpha-1 type I collagen; COL3A1, alpha-1 type III collagen; COL4A1, alpha-1 type IV collagen; 
TNc, tenascin c; calD1, caldesmon 1; VegFa, vascular endothelial growth factor a.
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Figure 5 In vitro culture of pcMc cells on acellular aortic valve matrix.
Notes: Morphological analysis of the ventricularis layer of aortic valve before (A) and after (a) Tricol treatment. (C, E, G, I) seM micrographs of pcMc grown on acellular 
aortic matrices for 7 days (D7), 14 days (D14), 28 days (D28), and 35 days (D35). DaPI staining of 5 µm thick sections of aortic valve before (B) and after (b) decellularization 
to investigate the TriCol efficacy of cellular removal and (D, F, H, J) to track the growth of seeded pCMC during 35 days of in vitro culture. The ventricularis and fibrosa 
surfaces are marked by white dotted line. White arrows indicate cells grown at the fibrosa surface. In the center, the scheme illustrates the shape and alignment pattern of 
pCMC during in vitro culture on aortic valve leaflets. SEM magnification: 1,000×; DaPI staining bar: 100 µm.
Abbreviations: seM, scanning electron microscopy; pcMc, porcine circulating multipotent cells; DaPI, 4,6-diamidino-2-phenylindole.
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Figure 6 Morphological analysis of the ventricularis layer of pulmonary valve before (A) and after (a) Tricol treatment. (C, E, G, I) seM micrographs of pcMc grown on 
acellular pulmonary matrices for 7 days (D7), 14 days (D14), 28 days (D28), and 35 days (D35). DaPI staining of 5 µm thick sections of pulmonary valve before (B) and after 
(b) decellularization to investigate the TriCol efficacy of cellular removal and (D, F, H, J) to track the growth and distribution of seeded pcMc during 35 days of in vitro 
culture.
Notes: The ventricularis and fibrosa layers are marked by white dotted line. White arrows indicate cells grown at the fibrosa surface. In the center, the scheme illustrates 
the shape and alignment pattern of pCMC during in vitro culture on pulmonary valve leaflets. SEM magnification: 1,000×; DaPI staining bar: 100 µm.
Abbreviations: seM, scanning electron microscopy; pcMc, porcine circulating multipotent cells; DaPI, 4,6-diamidino-2-phenylindole.
phenotypes, and are active in the control of structural 
integrity, remodeling, and repair of valve tissue.42 Recent 
findings suggest that valvular stem cells, reported as pro-
genitor VICs (pVICs) expressing CD34 and CD133,43 should 
play a pivotal role in the rescue of structural and mechanical 
properties of valve tissue under pathological conditions or 
during valve regeneration. Sex-mismatched murine chimeras 
and multilineage hematopoietic stem cell engraftments were 
used to provide the evidence that hematopoietic stem cells 
engraft into recipient heart valves expressing mRNA for pro-
collagen α1 and acquiring VICs-like phenotype.44 Although 
numerous attempts to identify potential pVICs have been 
made, at present, the evidence of circulating cells with high 
valvular differentiative potential is still limited. Compared 
to peripheral blood multipotent cells identified by other 
groups, such as BM-MSC,29,45 hematopoietic stem cells,46 
endothelial progenitor cells,47,48 blood-derived MSCs,49 and 
monocyte-derived multipotential cells,50 pCMC showed 
similar fibroblastic morphology, ex vivo expansion potential, 
and multidifferentiative activities but diverged from them 
for immunophenotypic features. Basically consisting of 
endothelial/hematopoietic progenitors (CD133+, CD34+)47 
and MSCs (CD44+, CD106+, CD90+, α-SMA+),51–53 pCMC 
activated differential valve patterning after long-term in vitro 
culture on the ventricularis surface of AV and PV matrices, 
demonstrating to “sense” the nanopatterned surface and 
mechanical heterogeneity of valve scaffolds and thus to 
“reprogram” their functionality accordingly.
Showing hematopoietic origin (CD133+/CD34+) but 
not mature phenotype (CD45-), pCMC were hypothesized 
to derive from bone marrow. The expression of adhesion 
molecules such as CD44, the hyaluronan receptor,51 and 
α-SMA, a contractile actin isoform,28,53 defined their ability 
to adhere to osteoblastic niche. In contrast, CD106 (vascular 
cell adhesion protein 1) and CD90 (thymus cell antigen-1) 
were probably indicative of their ability of extravasation 
and migration54 into circulation constitutively or following 
specific stimulation (anesthesia, trauma, surgery). The low 
expression of swine leukocyte antigen DR clearly confirmed 
the presence of a hierarchical organization in pCMC, where 
multipotent stem cells could generate cells with decreased 
stemness grade and lineage commitment potential.
An ideal HV must serve in vivo as an initial guiding struc-
ture for cell attachment and tissue development. ECM pro-
teins are important structural and regulatory components of 
tissues, and their expression and organization are critical for 
the correct functioning of native tissue and engineered con-
structs. The ECM nanostructures serve not only as a mechani-
cal support but also as a dynamic structure providing signals 
and cues to adherent cells, storing and releasing growth 
factors, and thus controlling cellular behavior.13 Although 
an enormous progress has been made in understanding the 
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Figure 7 Immunodetection of cD44 (A–F), cD106 (G–L), and vWF (M–R) performed on aVl and PVl seeded with pcMc and cultured in vitro for 7 days (D7) and 
35 days (D35). 
Notes: The expression of target markers in aortic (aV) and pulmonary (PV) native valves (NV) was also reported. Bar: 10 µm.
Abbreviations: pcMc, porcine circulating multipotent cells; vWF, von Willebrand factor.
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response of multipotent cells to the signaling of decellularized 
heart valve matrices, there are several important questions 
that remain unanswered concerning whether graft-colonizing 
stem cells could give rise to a complex three-layered network 
by sensing only chemical signals and nanostructures of valve 
ECM. In this work, TriCol matrices seeded with pCMC and 
cultured under no-flow condition showed to be a useful in 
vitro model for studying the impact of ECM hemodynamics 
and surface topography on the regeneration potential of valve 
conduits. After long-term culture, pCMC showed to be com-
mitted versus VIC- and VEC-like phenotypes on pulmonary 
leaflet, as suggested by the expression of structural markers 
typically expressed in fibrosa (collagen 1 and 3), spongiosa 
(TNC), ventricularis (FBN1 and emilin), and endothelium 
(VEGFA). Conversely, the cells responded to the different 
hemodynamic microenvironment and mechanical stretch of 
aortic heart valve conduits,55 promoting collagen remodeling 
through the expression of MMP256 and MMP13.57 Interest-
ingly, the expression of MMP2 could suggest also an acquired 
migratory potentiality by pCMC, in agreement with data 
reported by Shelton and Yutzey.58 As already reported in 
preclinical studies,19 AVs have been shown to sustain the 
process of endothelization by stimulating the production of 
VEGFA and collagen 3 and 4.59 The acquisition of VEC-like 
phenotype43 was further demonstrated in both leaflets by the 
expression of von Willebrand factor protein.
The biological response of pCMC could be crucial during in 
vivo implant regeneration as both re-endothelization and remod-
eling of collagenous/elastic network are essential processes to 
avoid thrombosis and preserve the structural/functional integrity 
of valve implants. Valve biology and biomechanics are strictly 
correlated to each other, and the nanostructural composition 
of the heart valve tissue determines its nonlinear stress–strain 
characteristics. Thus, alterations of structural components 
during the regeneration of valve substitutes reflect on the bal-
ance between external (blood, heart) and internal mechanical 
forces provoking valve dysfunction. The expression of TNC 
in both aortic and pulmonary conduits further suggested the 
great potentiality of TriCol valve matrices to sustain cellular 
functionality. TNC60 is a matricellular protein that is expressed 
in a spatiotemporal-restricted manner, during early stages of 
development and tissue remodeling. In our study, the expression 
of TNC could be indicative of an increased elasticity of matrix 
that is functional to preserve the implants from mechanical 
stretch. Taken into account that 1) elastin is essential for provid-
ing extensibility to valve tissue6,13 and 2) the explanted valve 
conduits from preclinical animal model evidenced no tissue 
disruption, the absent expression of emilin and FBN1 in aortic 
matrices could suggest that the decellularization method did not 
affect the elastic fiber. Thus, the cells could be stimulated to 
essentially enrich their microenvironment of collagenous matrix 
that is more in AV compared to pulmonary one.
In vitro studies on valves engineered with endothelial 
progenitor cells, smooth muscle cells, and multipotential 
stem cells significantly demonstrated that static and dynamic 
mechanical forces of decellularized matrices influence cells 
in viability, morphological changes, valve colonization, and 
biosynthetic activity. Hyaluronan is an important compo-
nent of valve hydrated matrix providing physical support 
for mechanical function and cell migration.40 It is reported 
that CD106 expression downregulates in senescent MSCs61 
because of the reduced synthesis of hyaluronan during in vitro 
culture expansion. In our work, after long-term culture, the 
expression of adhesion molecules CD44 and CD106 was 
shown to be preserved, suggesting that TriCol matrices are 
functional to guarantee long-term cell in vitro viability. Being 
expressed in undifferentiated and differentiated cells, CD44 
is hypothesized to play a pivotal role in mediating the bind-
ing of pCMC to the stem cell niche and the colonization of 
tissues enriched of hyaluronan such as heart valves.
Finally, we also demonstrated that the morphological 
features of VECs could be depending not only on blood flow 
pressure but also on ECM/cell interactions. In agreement with 
data reported by Butcher and Markwald,41 SEM of pCMC 
showed a differential morphological pattern of response to 
AVL and PVL but comparable with that of VECs from native 
valves. In AV, VECs of both inflow and outflow layers are 
aligned with their long axis parallel to underlying ECM com-
ponents organized circumferentially, and thus perpendicular to 
the direction of flow.62 In the absence of an aligned substrate, 
VECs align perpendicular to flow.63 Consistent with data previ-
ously reported by Butcher et al,64 pCMC strongly demonstrated 
under static culture conditions that the adhesion of VEC cells to 
ECM modulates cellular shape according to internal mechani-
cal forces. Moreover, this cellular response could involve the 
formation of more prominent stress fibers along the long axis 
of valvular cells in AV due to the robust fibrous collagenous 
and elastic extracellular network. Stress fibers are contractile 
actomyosin bundles that exert a fundamental role in various 
cellular processes such as morphogenesis, migration, cytoki-
nesis, endocytosis, and phagocytosis.65 During ECM remod-
eling, the structure and dynamics of actin filament networks 
are regulated in their nucleation, elongation, and disassembly 
by a large array of proteins.66 In our studies, the expression of 
CALD167 further suggested a differential cytoskeleton reorga-
nization driven by ECM nanopatterned structure.65
 
In
te
rn
at
io
na
l J
ou
rn
al
 o
f N
an
om
ed
ici
ne
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
93
.5
1.
37
.2
26
 o
n 
21
-N
ov
-2
01
6
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
International Journal of Nanomedicine 2016:11 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
5053
Differential stem cell commitment on heart valve matrices
Conclusion
Both ECM topography and shear stresses affect cellular and 
tissue biological activities. Sensing the local tissue mechanical 
environment and ECM nanostructures, valve cells mediate 
specific molecular changes to maintain valve homeostasis, 
adapt to an altered stress state, or repair injuries through tis-
sue remodeling. In this work, we isolated circulating multi-
potent cells from minipig peripheral blood and used them to 
explore the potential of in vitro repopulation of acellular heart 
valves. Based on their origin from peripheral blood, pCMC 
are hypothesized in vivo to exert a critical role to 1) homeo-
statically replenish valve cells, 2) participate in regenerative 
response following chemical (anesthesia) or physical (trauma) 
stimuli, and 3) contribute to hetero- or allograft colonization 
promoting the endothelialization and cell ingrowth of prosthe-
sis. Due to their ability to sense biomechanical stress within 
graft and modulate transcriptional activity accordingly, pCMC 
could be a useful in vitro model for testing the suitability of 
implants for “guided tissue engineering” applications.
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Supplementary material
Figure S1 Data from one-step rT-Pcr analysis were analyzed using Imagelab software.
Notes: The quantification of amplicon density band was measured for each target gene considering three independent experiments performed in triplicate. Expression levels 
were reported as ratio within target and housekeeping (GAPDH) gene expression level. Statistical significance was calculated by the Wilcoxon test comparing the expression 
profile of 1) pCMC grown on polystyrene dishes and control native valves (AV, *P#0.05) and (PV, P#0.05), or 2) pCMC cultured on valve leaflets against samples cultured 
for 7 days (D7) (P#0.05).
Abbreviations: rT-Pcr, reverse transcription–polymerase chain reaction; gaPDh, glyceraldehyde 3-phosphate dehydrogenase; pcMc, porcine circulating multipotent 
cells; MMP, matrix metalloproteinase; FBN1, fibrillin; EMILIN1, emilin 1; COL1A1, alpha-1 type I collagen; COL3A1, alpha-1 type III collagen; COL4A1, alpha-1 type IV 
collagen; TNc, tenascin c; calD1, caldesmon 1; VegFa, vascular endothelial growth factor a.
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